Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases

• Prif Awduron: Atsunori Tsuchiya (Awdur), Suguru Takeuchi (Awdur), Takahiro Iwasawa (Awdur), Masaru Kumagai (Awdur), Takeki Sato (Awdur), Satoko Motegi (Awdur), Yui Ishii (Awdur), Youhei Koseki (Awdur), Kei Tomiyoshi (Awdur), Kazuki Natsui (Awdur), Nobutaka Takeda (Awdur), Yuki Yoshida (Awdur), Fusako Yamazaki (Awdur), Yuichi Kojima (Awdur), Yusuke Watanabe (Awdur), Naruhiro Kimura (Awdur), Kentaro Tominaga (Awdur), Hiroteru Kamimura (Awdur), Masaaki Takamura (Awdur), Shuji Terai (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: BMC, 2020-06-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19) and the ensuing worldwide pandemic. The spread of the virus has had global effects such as activity restriction, economic stagnation, and collapse...